Treatment with imiquimod and surgical excision of a patient with extramammary Paget´s disease. Case report
Main Article Content
Keywords
Paget´s disease, Extramammary, Skin neoplasms, Imiquimod
Abstract
Extramammary Paget´s disease (EMPD) is a less common cutaneous type of cancer. It presents as erythematous plaques most frequently located in the genital region, perianal skin, and other cutaneous sites rich in apocrine glands, but it also may originate from keratinocytic stem cells. Recently, imiquimod has been used for the management of primary or relapsing extramammary Paget´s disease. Complete healing, without recurrence, of extramammary Paget´s disease in patients whom were treated topically with 5 % imiquimod cream was observed. We report a 78 year-old patient with scrotal and perianal extramammary Paget´s disease treated with imiquimod cream in both lesions and subsequently with surgical excision in scrotum for the management of relapsing disease.
References
Paget J. Sobre la enfermedad de la areola mamaria que preceden al cáncer de la glándula mamaria. St. Bartholomew Hosp Rep 1874; 10: 87-89.
Crocker HR. La enfermedad de Paget afecta el escroto y el pene. Trans Pathol Soc Lond 1888-1889; 40: 187-191.
Kageyama N, Izumi AK. Enfermedad de Paget extramamaria escrotal bilateral en un hombre chino. Int J Dermatol 1997; 36 (9): 695 - 697.
Chanda JJ. Enfermedad de Paget extramamaria: pronóstico y relación con malignidad interna. J Am Acad Dermatol 1985; 13 (6): 1009 - 1014.
Enfermedad de Niedt G. Paget Es: Rigel DS, Friedman RJ, editores. Cáncer de la piel. China: Elsevier; 2005. p. 303-309.
Balducci L, Crawford D, Smith G, Lambuth B, McGehee R, Hardy C. Enfermedad de Paget extramamaria: una revisión anotada. Cancer Invest 1988; 6 (3) 293-303.
Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget´s disease. Br J Dermatol 2000;142(1):59-65.
Chen YH, Wong TW, Lee JY. Depigmented genital extramammary Paget´s disease: a possible histogenetic link to Toker’s clear cells and clear cell papulosis. J Cutan Pathol 2001;28(2):105-108.
Wick M, Swanson P, Barnhill R. Sweat gland tumors. En: Barnhill RL, editor. Textbook of dermatopathology. New York: McGraw-Hill; 1998. p. 646- 647, 652.
Helm KF, Goellner JR, Peters MS. Immunohistochemical stains in extramammary Paget´s disease. Am J Dermatopathol 1992;14(5): 402-407.
Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget´s disease: a report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991;67(4): 933-938.
Koh KBH, Nazarina AR. Paget´s disease of the scrotum: report of a case with underlying carcinoma of the prostate. Br J Dermatol 1995;133 (2):306-307.
Chaudhuri SR, Smoller BR. Extramammary Pa-get´s disease: diagnosis and disease pattern. Cutis 1992;50(3):195-196.
Allan SJR, McLaren K, Aldridge RD. Paget´s disease of the scrotum: a case exhibiting positive prostate-specific antigen staining and associated prostatic adenocarcinoma. Br J Dermatol 1998;138 (4):689-691.
Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000; 43(1 Pt 2):S1-S5.
Tomai MA, Imberston LM, Stanczak TL, Tygrett LT, Waldschmidt TJ. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Cell Immunol 2000;203(1):55-65.
Perez MA, LaRossa DD, Tomaszewski JE. Paget´s disease primarily involving the scrotum. Cancer 1989;63(5):970-975.
Sauder DN. Propiedades inmunomoduladoras y farmacológicas de imiquimod. J Am Acad Dermatol 2000; 43 (1 Pt 2): S6-S11.
Kagy MK, Amonette R. El uso de imiquimod crema al 5% para el tratamiento de carcinomas basocelulares superficiales en un paciente con síndrome de nevo basocelular. Dermatol Surg 2000; 26 (6): 577-579.
Cohen PR, Schulze KE, Tschen JA, Hetherington GW, Nelson BR. Tratamiento de la enfermedad de Paget extramamaria con crema tópica de imiquimod: informe de un caso y revisión de la literatura. South Med J 2006; 99 (4): 396-402.
Del Rosso JQ. El tratamiento de infecciones virales y cánceres de piel no melanoma. Cutis 2007; 79 (4 Suppl): 29-35.